The impact of changes in population blood pressure on hypertension prevalence and control in China
- PMID: 32003937
- PMCID: PMC8030006
- DOI: 10.1111/jch.13820
The impact of changes in population blood pressure on hypertension prevalence and control in China
Abstract
In China, there are approximately 250 million adults who have hypertension with low rates of awareness, treatment and control. Changes in lifestyles at a population level have the potential to enhance or deteriorate the prevention and control of hypertension. We used data from a regional hypertension survey to examine the impact of 2/1 mm Hg decreases or increases in population blood pressure on hypertension prevalence, and rates of unawareness of the hypertension diagnosis, treatment, and control. The primary analysis was based on the average blood pressure of respondents from three visits and a diagnostic threshold of 140/90 mm Hg for hypertension. Secondary analyses examined average blood pressure from the first survey visit and also a diagnostic threshold of 130/80 mm Hg for hypertension. The baseline hypertension prevalence was 33.4%, and rates of unawareness of the hypertension diagnosis, treatment, and control were 74.2%, 25.8%, and 9.7%, respectively. Decreases or increases in blood pressure by 10/5 mm Hg resulted in changes in hypertension prevalence (22.1% vs 53.4%) and rates of unawareness of the diagnosis (60.9% vs 83.8%), treatment (39.1% vs 16.2%), and control (21.2% vs 3.6%), respectively. Similar trends were seen in the secondary analyses. Population changes in lifestyle could have a very large impact on the prevalence and control of hypertension in China. The results support implementation of programs to improve population lifestyles while implementing health services policies to enhance the clinical management of hypertension.
Keywords: clinical management of hypertension; diet/nutrition/hypertension; hypertension; prevention; public health.
© 2020 Wiley Periodicals, Inc.
Conflict of interest statement
NRCC was a paid consultant to the Novartis Foundation (2016‐2017) to support their program to improve hypertension control in low‐ to middle‐income countries which includes travel support for site visits and a contract to develop a survey. NRCC has provided paid consultative advice on accurate blood pressure assessment to Midway Corporation (2017) and is an unpaid member of World Action on Salt and Health (WASH). The other authors have no conflicts of interest to declare.
References
-
- Li Y, Wang L, Feng X, et al. Geographical variations in hypertension prevalence, awareness, treatment and control in China: findings from a nationwide and provincially representative survey. J Hypertens. 2018;36(1):178‐187. - PubMed
-
- Hu S, Gao R, Liu L, et al. Summary of the 2018 report on cardiovascular diseases in China. Chin Circulation J. 2019;34:209.
-
- Li Y, Yang L, Wang L, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol. 2017;227:516‐523. - PubMed
-
- Global Burden of Disease Website . Institute for health metrics and evaluation. http://vizhub.healthdata.org/gbd-compare/. Accessed July 13, 2019.
-
- Institute of Medicine of the National Academies . A Population‐Based Policy and Systems Change Approach to Prevent and Control Hypertension‐Brief Report. Washington, D.C.: National Academy Press; 2010. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
